Bridgewater Associates’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,926
| Closed | -$475K | – | 950 |
|
|
2024
Q1 | $475K | Sell |
32,926
-4,907
| -13% | -$70.9K | ﹤0.01% | 629 |
|
|
2023
Q4 | $814K | Sell |
37,833
-4,434
| -10% | -$95.4K | ﹤0.01% | 660 |
|
|
2023
Q3 | $812K | Buy |
42,267
+3,996
| +10% | +$76.8K | ﹤0.01% | 637 |
|
|
2023
Q2 | $973K | Sell |
38,271
-4,230
| -10% | -$108K | 0.01% | 580 |
|
|
2023
Q1 | $1.54M | Buy |
42,501
+1,566
| +4% | +$56.6K | 0.01% | 504 |
|
|
2022
Q4 | $1.62M | Sell |
40,935
-13,980
| -25% | -$554K | 0.01% | 564 |
|
|
2022
Q3 | $2.56M | Buy |
54,915
+105
| +0.2% | +$4.89K | 0.01% | 510 |
|
|
2022
Q2 | $2.4M | Buy |
54,810
+6,075
| +12% | +$266K | 0.01% | 641 |
|
|
2022
Q1 | $3.53M | Buy |
48,735
+11,643
| +31% | +$842K | 0.01% | 548 |
|
|
2021
Q4 | $3.01M | Buy |
37,092
+4,758
| +15% | +$386K | 0.02% | 401 |
|
|
2021
Q3 | $3.76M | Sell |
32,334
-2,439
| -7% | -$284K | 0.02% | 334 |
|
|
2021
Q2 | $5.77M | Buy |
+34,773
| New | +$5.77M | 0.04% | 310 |
|